olaparib, durvalumab, tremelimumab clinical trials

Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment

This study looks at combining two types of immunotherapy with an existing drug called olaparib for people with certain advanced solid cancers whose cancer has already been treated. It focuses on patients with specific gene changes that might make the treatment more effective.